In patients with both NSCLC histology and NSCLC metastatic stage, serum IGF-1/IGFBP3 levels are significantly higher than those measured in subjects with SCLC histology and non-metastatic stage of NSCLC [102]. The gene discussed is IGFBP3; the disease is non-small cell lung carcinoma.